Yan-Shen Shan

Professor

Institute of Clinical Medicine

Emailysshan@mail.ncku.edu.tw

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Education

2004 PhD, Institute of Clinical Medicine, National Cheng Kung University

Experience

1998.08~Present Surgeon/Department of Surgery, NCKUH
2002.08~2008.07 Assistant professor/Department of Surgery, NCKU
2008.08~ 2012.07 Associate professor/Department of Surgery, NCKU
2010.08~2012.07 Associate professor/Institute of Clinical Medicine, NCKU
2010.10~Present Convener of UGI Cancer/NCKUH
2012.08~2016.07 Professor/Institute of Clinical Medicine, NCKU
2016.08~Present Director/Department of Clinical Medical Research, NCKUH
2016.08~Present Distinguished Professor/Institute of Clinical Medicine, NCKU
2017.08~Present Director/Institute of Clinical Medicine, NCKU

Research Interests

Gastrointestinal physiology
GI Clinical Oncology
Tumor microenvironment (interaction between cancer cells and stromal cells)
Liver Fibrosis and Regeneration

Fingerprint

Dive into the research topics where Yan-Shen Shan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

12 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots or

1 Active
24 Finished

台灣上消化道癌症臨床試驗合作聯盟 IV
Shan, Y.
20-05-01 → 21-04-30
Project: Research project
A20在胃癌的鐘擺化療法中造成藥物阻抗所扮演角色之研究
Shan, Y.
19-08-01 → 20-07-31
Project: Research project
剖析胰臟癌發生過程中免疫調節成份之功能性變化-癌細胞與免疫浸潤巨噬細胞交互作用對胰臟癌生成過程中的免疫調節之影響(3/3)
Shan, Y.
19-08-01 → 20-07-31
Project: Research project
A20在胃癌的鐘擺化療法中造成藥物阻抗所扮演角色之研究
Shan, Y.
19-08-01 → 20-07-31
Project: Research project
剖析胰臟癌發生過程中免疫調節成份之功能性變化-癌細胞與免疫浸潤巨噬細胞交互作用對胰臟癌生成過程中的免疫調節之影響(3/3)
Shan, Y.
19-08-01 → 20-07-31
Project: Research project

3230 Citations
25 h-Index
174 Article
5 Review article
4 Conference contribution
2 Comment/debate
More
- 1 Chapter

c-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation
Chang, T. M., Chu, P. Y., Hung, W. C., Shan, Y. S., Lin, H. Y., Huang, K. W., Chang, J. S., Chen, L. T. & Tsai, H. J., 2021 Jan, In: Cancer Science. 112, 1, p. 243-253 11 p.
Research output: Contribution to journal › Article › peer-review

Open Access
Development of possible next line of systemic therapies for gemcitabine-resistant biliary tract cancers: A perspective from clinical trials
Chiang, N. J., Chen, L. T., Shan, Y. S., Yeh, C. N. & Chen, M. H., 2021 Jan, In: Biomolecules. 11, 1, p. 1-20 20 p., 97.
Research output: Contribution to journal › Review article › peer-review

Open Access
Upregulation of peroxisome proliferator-activated receptor-α and the lipid metabolism pathway promotes carcinogenesis of ampullary cancer
Wang, C. Y., Chao, Y. J., Chen, Y. L., Wang, T. W., Phan, N. N., Hsu, H. P., Shan, Y. S. & Lai, M. D., 2021, In: International Journal of Medical Sciences. 18, 1, p. 256-269 14 p.
Research output: Contribution to journal › Article › peer-review

Open Access
A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma–TCOG T1211 study
Chiang, N. J., Tsai, K. K., Hsiao, C. F., Yang, S. H., Hsiao, H. H., Shen, W. C., Hsu, C., Lin, Y. L., Chen, J. S., Shan, Y. S. & Chen, L. T., 2020 Jan, In: European Journal of Cancer. 124, p. 123-130 8 p.
Research output: Contribution to journal › Article › peer-review
4 Citations (Scopus)
An Open-Label, Single-Arm, Two-Stage, Multicenter, Phase II Study to Evaluate the Efficacy of TLC388 and Genomic Analysis for Poorly Differentiated Neuroendocrine Carcinomas
Chen, M. H., Chou, W. C., Hsiao, C. F., Jiang, S. S., Tsai, H. J., Liu, Y. C., Hsu, C., Shan, Y. S., Hung, Y. P., Hsich, C. H., Chiu, C. H., Liu, T. C., Cho, S. F., Liu, T. W. & Chao, Y., 2020 May 1, In: Oncologist. 25, 5, p. e782-e788
Research output: Contribution to journal › Article › peer-review

Open Access